Experimental CAR T-Cell therapy targets tough lymphoma cases
NCT ID NCT06256484
First seen Mar 25, 2026 · Last updated May 16, 2026 · Updated 6 times
Summary
This early-stage study tested a new treatment called ATA3219 for people with a type of blood cancer (B-cell non-Hodgkin lymphoma) that had come back or stopped responding to other treatments. The therapy uses specially engineered immune cells from a healthy donor to attack cancer cells. The main goals were to check safety and find the right dose. The study was stopped early after enrolling only one person, so results are very limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AdventHealth Cancer Institute
Orlando, Florida, 32804, United States
-
Fiona Stanley Hospital
Murdoch, Western Australia, 6150, Australia
-
Norton Cancer Institute - Saint Matthews
Louisville, Kentucky, 40207, United States
-
Princess Alexandra Hospital
Woolloongabba, Queensland, 4102, Australia
-
Sidney Kimmel Cancer Center - Jefferson Health
Philadelphia, Pennsylvania, 19107, United States
-
University of Virgina
Charlottesville, Virginia, 22908, United States
Conditions
Explore the condition pages connected to this study.